Controlling nanoparticle targeting: from physicochemical design to molecular recognition.

Area of Science:

• Nanomedicine and Drug Delivery
• Biotechnology and Biomedical Engineering
• Materials Science in Medicine

Background:

• Nanoparticles offer advanced drug delivery, improving biodistribution, targeting, and therapeutic efficacy for various diseases.
• Nanoparticle design integrates physicochemical properties with biological targeting mechanisms for enhanced performance.
• Stimuli-responsive platforms exploit pathological tissue characteristics for controlled drug release and personalized medicine.

Purpose of the Study:

• To critically examine nanoparticle targeting strategies in nanomedicine.
• To discuss the advantages, limitations, and translational potential of different nanoparticle design approaches.
• To explore how dynamic phenomena like protein corona formation influence nanoparticle behavior and targeting.

Main Methods:

• Review and critical analysis of current nanoparticle targeting strategies.
• Examination of physicochemical and biopharmaceutical properties influencing nanoparticle design.
• Discussion of stimuli-responsive platforms and their exploitation of pathological microenvironments.

Main Results:

• Nanoparticle design requires careful integration of material properties and biological targeting.
• Stimuli-responsive systems offer precise payload release by exploiting disease-specific conditions.
• Protein corona formation and immune responses present both challenges and opportunities for nanoparticle targeting.

Conclusions:

• Targeting strategies are crucial for optimizing nanomedicine efficacy and safety.
• Understanding dynamic nanoparticle-biological interactions is key for clinical translation.
• Future nanomedicine development should focus on tailored nanoparticle design for personalized therapies.